(Q39749515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

review article

1 reference

title

Techniques of postmarketing surveillance. An overview (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

Carson JL

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

Strom BL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 July 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

237-246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

A unique postmarket outpatient surveillance program of cimetidine: report on phase II and final summary

28 September 2019

cites work

1 reference

12 December 2020

The Commission on Professional and Hospital Activities--Professional Activity Study. A national resource for the study of rare illnesses

1 reference

12 December 2020

A compilation of abstracts and an index of articles published by the Boston Collaborative Drug Surveillance Program

1 reference

12 December 2020

Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton

1 reference

12 December 2020

Food and drugs: why different approaches to their safety?

1 reference

12 December 2020

Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?

1 reference

12 December 2020

The computerized on-line Medicaid pharmaceutical analysis and surveillance system: a new resource for postmarketing drug surveillance

1 reference

12 December 2020

The practitioner's role in detection of adverse drug reactions

1 reference

12 December 2020

Post-marketing studies of drug efficacy: how?

1 reference

12 December 2020

The epidemiological evaluation of drugs

1 reference

12 December 2020

Postmarketing follow-up at Group Health Cooperative of Puget Sound

1 reference

12 December 2020

Can Postmarketing Surveillance Help to Effect Optimal Drug Therapy?

1 reference

12 December 2020

How good are articles on adverse drug reactions?

1 reference

12 December 2020

Case-control studies in the assessment of drug safety

1 reference

12 December 2020

Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women

1 reference

12 December 2020

Monitoring of adverse reactions to drugs in the United Kingdom.

1 reference

12 December 2020

Prescription-event monitoring. A preliminary study of benoxaprofen and fenbufen

1 reference

12 December 2020

Sample size requirements in cohort and case-control studies of disease

1 reference

12 December 2020

Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?

1 reference

12 December 2020

Discovering Adverse Drug Reactions

1 reference

12 December 2020

Maternal valproic acid and congenital neural tube defects

1 reference

12 December 2020

The discovery of drug-induced illness

1 reference

12 December 2020

Post-marketing studies of drug efficacy: why?

1 reference

12 December 2020

Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods

1 reference

12 December 2020

Lung-cancer mortality as related to residence and smoking histories. I. White males

1 reference

12 December 2020

Postmarketing studies of drug efficacy: when must they be randomized?

1 reference

12 December 2020

Adverse reactions to new drugs

1 reference

12 December 2020

Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems

1 reference

12 December 2020

Adverse drug reaction monitoring: doing it the French way

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03259840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3537618%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference